BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36104079)

  • 1. Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.
    Imterat M; Bizzarri N; Fruscio R; Perrone AM; Traut A; du Bois A; Rosati A; Ferrari D; De Iaco P; Ataseven B; Ergasti R; Volontè S; Tesei M; Heitz F; Perri MT; Concin N; Fanfani F; Scambia G; Fagotti A; Harter P
    Int J Gynecol Cancer; 2023 Jan; 33(1):42-49. PubMed ID: 36104079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
    Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():131-136. PubMed ID: 30685661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma.
    Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Mikami M; Enomoto T; Katabuchi H; Aoki D
    J Gynecol Oncol; 2020 Jul; 31(4):e45. PubMed ID: 32026659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
    Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture.
    Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Suzuki T; Ino K; Kawai M; Mizutani S
    Oncology; 2003; 65(1):29-36. PubMed ID: 12837980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.
    Plett H; Ricciardi E; Vacaru V; Ramspott JP; Colombo N; Sehouli J; du Bois A; Garbi A; Richter R; Ataseven B; Aletti G; Braicu E; Heitz F; Portuesi R; Muallem MZ; Dagres T; Parma G; Roser E; Traut A; Multinu F; Harter P
    Int J Gynecol Cancer; 2023 May; 33(5):734-740. PubMed ID: 36759002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult Granulosa Cell Tumors of the Ovary: A Retrospective Study of 36 FIGO Stage I Cases with Emphasis on Prognostic Pathohistological Features.
    Babarović E; Franin I; Klarić M; Ferrari AM; Karnjuš-Begonja R; Eminović S; Ostojić DV; Vrdoljak-Mozetič D
    Anal Cell Pathol (Amst); 2018; 2018():9148124. PubMed ID: 30186737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oncologic outcome and its prognostic indicators in reproductive-age women with ovarian clear-cell carcinoma.
    Kajiyama H; Suzuki S; Yoshikawa N; Niimi K; Kawai M; Shibata K; Kikkawa F
    Arch Gynecol Obstet; 2019 Sep; 300(3):717-724. PubMed ID: 31165243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
    Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
    Nasioudis D; Heyward QD; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Latif NA
    Int J Gynecol Cancer; 2022 Feb; 32(2):165-171. PubMed ID: 34952848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
    Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
    Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of fertility-sparing surgery in young women with stage I endometrioid epithelial and mucinous ovarian cancer: A population-based analysis.
    Li J; Qiao H; Liu Y; Huang C; Cheng A; Lin Z; Wang L; Lu H
    Eur J Surg Oncol; 2024 Jan; 50(1):107276. PubMed ID: 38064863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analysis and obstetric outcomes in patients with early stage ovarian cancer undergoing fertility-sparing surgery.
    Birge Ö; Bakır MS; Doğan S; Tuncer HA; Simsek T
    J Ovarian Res; 2022 Dec; 15(1):135. PubMed ID: 36564811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma.
    Hsieh SF; Lau HY; Wu HH; Hsu HC; Twu NF; Cheng WF
    Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30795566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis.
    Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Mogi K; Kajiyama H
    J Gynecol Oncol; 2021 Sep; 32(5):e66. PubMed ID: 34378361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.
    Köbel M; Kalloger SE; Santos JL; Huntsman DG; Gilks CB; Swenerton KD
    Gynecol Oncol; 2010 Jan; 116(1):50-6. PubMed ID: 19822358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging system.
    Nguyen HN; Averette HE; Hoskins W; Sevin BU; Penalver M; Steren A
    Cancer; 1993 Nov; 72(10):3007-11. PubMed ID: 8221569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study.
    Suh DH; Park JY; Lee JY; Kim BG; Lim MC; Kim JW; Bae DS; Park SY; Nam JH; Kim K; No JH; Kim YB
    Gynecol Oncol; 2015 Jun; 137(3):412-7. PubMed ID: 25868967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.